SciSparc (SPRC) Cash from Operations (2016 - 2018)
SciSparc (SPRC) posted Cash from Operations of 2767000.0 for Q4 2018, down 207.44% sequentially from 900000.0 in Q3 2018, and down 87.59% YoY from 22302322.4 in Q4 2017.
SciSparc (SPRC) Cash from Operations (2016 - 2018) Analysis & Trends
SciSparc has reported Cash from Operations for 3 years, with the latest figure at 2767000.0 in Q4 2018.
- Quarterly Cash from Operations fell 87.59% year-over-year to 2767000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 7132000.0 (down 55.75% YoY) and the FY2025 annual result came in at 4137000.0, up 18.95% from the prior year.
- Cash from Operations slipped to 2767000.0 in Q4 2018 per SPRC's latest filing, from 900000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 18000.0 in Q4 2016 and troughed at 2767000.0 in Q4 2018.
- A 3-year average of 1168181.82 and a median of 1010000.0 in 2017 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2017 and 2018: Cash from Operations sank 8094.44% in 2017, then rose 10.89% in 2018.
- Over 3 years, Cash from Operations stood at 18000.0 in 2016, then tumbled by 8094.44% to 1475000.0 in 2017, then sank by 87.59% to 2767000.0 in 2018.
- According to Business Quant data, Cash from Operations over the past three periods registered 2767000.0, 900000.0, and 1835000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -2.77 Mn |
| Dec 31, 2018 | -2.77 Mn |
| Sep 30, 2018 | -900,000.00 |
| Sep 30, 2018 | -900,000.00 |
| Jun 30, 2018 | -1.84 Mn |
| Jun 30, 2018 | -1.84 Mn |
| Mar 31, 2018 | -1.63 Mn |
| Mar 31, 2018 | -1.63 Mn |
| Dec 31, 2017 | -1.48 Mn |
| Dec 31, 2017 | -1.48 Mn |
| Sep 30, 2017 | -1.01 Mn |
| Sep 30, 2017 | -1.01 Mn |
| Jun 30, 2017 | -1.90 Mn |
| Jun 30, 2017 | -1.90 Mn |
| Mar 31, 2017 | -194,000.00 |
| Mar 31, 2017 | -194,000.00 |
| Dec 31, 2016 | -18,000.00 |
| Dec 31, 2016 | -18,000.00 |
| Sep 30, 2016 | -691,000.00 |
| Sep 30, 2016 | -691,000.00 |